
GC14349
SB525334
Also known as 6-[2-tert-butyl-5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinoxaline
SB525334 has been characterized as a potent and selective inhibitor of the transforming growth factor-beta1 (TGF-beta1) receptor, activin receptor-like kinase (ALK5)· SB525334 inhibited ALK5 kinase activity with an IC50 of 14·3nM
ChemicalCAS356559-20-1MW343.42FormulaC21H21N5
- CAS number
- 356559-20-1
- Molecular weight
- 343.42
- Formula
- C21H21N5
- Solubility
- ≥ 34·3mg/mL in DMSO, ≥ 23·8 mg/mL in EtOH
- InChIKey
- DKPQHFZUICCZHF-UHFFFAOYSA-N
- Catalogue number
- GC14349
- Brand
- GLPBIO
Computed properties PubChem CID 9967941 · XLogP 3.7 · TPSA 67.4 Ų · H-bond donors 1
- XLogP
- 3.7
- TPSA
- 67.4 Ų
- H-bond donors
- 1
- H-bond acceptors
- 4
- Rotatable bonds
- 3
- Heavy atoms
- 26
SMILES CC1=NC(=CC=C1)C2=C(N=C(N2)C(C)(C)C)C3=CC4=NC=CN=C4C=C3
Computed descriptors from PubChem (CID 9967941), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il